Smart Bandages Monitor and Tailor Treatment for Chronic Wounds
Smart bandages designed to monitor and tailor treatment for chronic wounds Smart Bandages with integrated pH and temperature sensors and electronically triggered drug release are designed to improve healing A team of engineers led by Tufts University has developed a...
Computer diagnoses Parkinson’s with behavioral tracking
Thousands of people do not know they have Parkinson’s disease. Eric Horvitz wants them to be able to find out — before the incurable neurodegenerative disorder progresses to its later stages. In his perfect world, they wouldn’t have to interrupt their daily routines. They could stay in their homes and offices, working on their computers, and their online activity would eventually trigger a message: A visit to the doctor is in order.
The beating brain: A video captures the organ’s rhythmic pulsations
A study recently published in the journal Magnetic Resonance in Medicine and co-authored by Stanford life-science research assistant Itamar Terem, then-postdoc Samantha Jane Holdsworth, PhD, (now at the University of Auckland) and several other Stanford colleagues describes a new imaging method that, by means of a kind of strobe-action amplification technique, is able to visually blow up the minute heartbeat-induced pulsations of the brain to produce mind-boggling video sequences such as the one you’ve hopefully taken a peek at here.
Neovii & Mundipharma Agreement for Solid Organ & Stem Cell Transplant
Neovii pharmaceuticals AG of Rapperswil, Switzerland and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.
ACROMEC Healthcare Pharma Cleanroom Contract Worth $6.2M
ACROMEC Limited (“ACROMEC”, SGX:43F), an established specialist engineering service provider in the field of controlled environments serving mainly the healthcare, biomedical, research and academia sectors, has secured three new contracts totaling approximately S6.2 million.
Dynacure secures €47 million financing to advance lead program into clinical development
Dynacure, a biotechnology company developing new treatments for patients affected by serious orphan disorders, announced today the completion of a €47 million financing round (~US$55 million) to advance its lead program into clinical development. Andera Partners (formerly Edmond de Rothschild Investment Partners) led the financing round, joined by Pontifax, Bpifrance, Kurma Partners and IdInvest Partners.
Pharmaceutical Plant in Skidel to Open in October
pharmaceutical plant in Skidel (Grodno Oblast) will be launched in October, the press service of the Council of Republic told BelTA following the meeting between Speaker, curator of the Belarusian-Indian cooperation Mikhail Myasnikovich and Indian investors Jayant Kaushik, Alok Kumar (Lok-Beta Pharmaceuticals (I) Pvt. Ltd) and Director of OOO Novalok Kumar Manoranjan.
R&D Operations Hub to Open in Chengdu, China
R&D Operations Hub to Open in Chengdu, China Sanofi to further accelerate its scientific presence with the opening of a Global R&D Operations Hub in Chengdu, China Sanofi (EURONEXT: SAN) (NYSE: SNY) is launching a Global R&D Operations Hub with a...
Catalent Signs Agreement To Acquire Juniper Pharmaceuticals, Inc.
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has agreed to acquire Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR), including its Nottingham, U.K.-based Juniper Pharma Services division.
Boron Nitride Nanotubes New Nano Building Block
Boron nitride nanotubes, like their carbon cousins, are rolled sheets of hexagonal arrays. Unlike carbon nanotubes, they’re electrically insulating hybrids made of alternating boron and nitrogen atoms. Insulating nanotubes that can be functionalized will be a valuable building block for nanoengineering projects, Martí said. “
Polio Vaccine New Single Injection Approach
To create a single-injection vaccine, the MIT team encapsulated the inactivated polio vaccine in a biodegradable polymer known as PLGA. This polymer can be designed to degrade after a certain period of time, allowing the researchers to control when the vaccine is released.
